Identification of SLURP-1 as an epidermal neuromodulator explains the clinical phenotype of Mal de Meleda
Fiche du document
- doi: 10.1093/hmg/ddg320
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1093/hmg/ddg320
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/14506129
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/0964-6906
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_42136D8EED7F9
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Sujets proches
PhenotypesCiter ce document
F. Chimienti et al., « Identification of SLURP-1 as an epidermal neuromodulator explains the clinical phenotype of Mal de Meleda », Serveur académique Lausannois, ID : 10.1093/hmg/ddg320
Métriques
Partage / Export
Résumé
Mal de Meleda is an autosomal recessive inflammatory and keratotic palmoplantar skin disorder due to mutations in the ARS B gene, encoding for SLURP-1 (secreted mammalian Ly-6/uPAR-related protein 1). SLURP-1 belongs to the Ly-6/uPAR superfamily of receptor and secreted proteins, which participate in signal transduction, immune cell activation or cellular adhesion. The high degree of structural similarity between SLURP-1 and the three fingers motif of snake neurotoxins and Lynx1 suggests that this protein interacts with the neuronal acetylcholine receptors. We found that SLURP-1 potentiates the human alpha 7 nicotinic acetylcholine receptors that are present in keratinocytes. These results identify SLURP-1 as a secreted epidermal neuromodulator which is likely to be essential for both epidermal homeostasis and inhibition of TNF-alpha release by macrophages during wound healing. This explains both the hyperproliferative as well as the inflammatory clinical phenotype of Mal de Meleda.